Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-08-13

Clinical Trial Update: Rivastigmine for Intensive Care Unit (ICU) Delirium [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating rivastigmine for ICU delirium was terminated. The study, sponsored by UMC Utrecht, assessed rivastigmine for delirium in the i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rivastigmine (Rivastigmine)

Snippet

Sponsor: UMC Utrecht | Conditions: Delirium | Phase 4 | Status: TERMINATED